Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + Endocrine Therapy in HR+/HER2- Breast Cancer
NCT03969121Phase 3Completed
- Sponsor
- Kyoto Breast Cancer Research Network
- Start
- Jul 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by Kyoto Breast Cancer Research Network. Started Jul 2019; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03969121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03969121.